Protocol Ledger

NCT05638581 · Phase III · COMPLETED

Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

Interventional Phase III clinical trial protocol NCT05638581 sponsored by University of Alabama at Birmingham in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-07-27 Enrollment: 1,100 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05638581
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,100 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05638581
Protocol FieldVerified Registry Value
NCT IdentifierNCT05638581
Consolidated Lead SponsorUniversity of Alabama at Birmingham
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment1,100 participants (ACTUAL)
Registered Start Date2023-07-27
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI